Racial differences in survival and healthcare resource utilization among Medicaid-insured adults with metastatic castration-sensitive prostate cancer.

被引：0
|
作者：
DerSarkissian, Maral
Gupta, Deepshekhar
Ivanova, Jasmina
Niyazov, Alexander
Zanardo, Enrico
Guo, Tracy
Wang, Jingru
Duh, Mei Sheng
Freedland, Stephen J.
机构：
[1] Anal Grp Inc, Los Angeles, CA USA
[2] Anal Grp Inc, Menlo Pk, CA USA
[3] Pfizer Inc, New York, NY USA
[4] Anal Grp Inc, Denver, CO USA
[5] Anal Grp Inc, Boston, MA USA
[6] Anal Grp, Boston, MA USA
[7] Cedars Sinai Med Ctr, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
26
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Racial differences in survival and healthcare resource utilization among Medicaid-insured adults with metastatic castration-resistant prostate cancer.
    DerSarkissian, Maral
    Gupta, Deepshekhar
    Ivanova, Jasmina
    Niyazov, Alexander
    Zanardo, Enrico
    Guo, Tracy
    Wang, Jingru
    Duh, Mei Sheng
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] Racial Differences in Survival and Healthcare Resource Utilization Among Medicaid-Insured Adults With Metastatic Prostate Cancer
    Dersarkissian, Maral
    Arondekar, Bhakti
    Gupta, Deepshekhar
    Ivanova, Jasmina
    Niyazov, Alexander
    Zanardo, Enrico
    Guo, Tracy
    Wang, Jingru
    Duh, Mei Sheng
    Freedland, Stephen J.
    CLINICAL GENITOURINARY CANCER, 2025, 23 (02)
  • [3] Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer
    George, Daniel J.
    Agarwal, Neeraj
    Ramaswamy, Krishnan
    Klaassen, Zachary
    Bitting, Rhonda L.
    Russell, David
    Sandin, Rickard
    Emir, Birol
    Yang, Hongbo
    Song, Wei
    Lin, Yilu
    Hong, Agnes
    Gao, Wei
    Freedland, Stephen J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (04) : 765 - 775
  • [4] Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer
    Heath, Elisabeth, I
    Dyson, Gregory E.
    Cackowski, Frank C.
    Hafron, Jason
    Powell, Isaac
    CLINICAL GENITOURINARY CANCER, 2022, 20 (06) : 524 - 532
  • [5] Evaluating the optimal sequence of immunotherapy and docetaxel in men with metastatic castration-sensitive prostate cancer.
    Chandran, Elias Bin Aris
    Atiq, Mohammad O.
    Donahue, Renee Nicole
    Karzai, Fatima
    Bilusic, Marijo
    Marte, Jennifer L.
    Arlen, Philip M.
    Cordes, Lisa M.
    Owens, Helen
    Hankin, Amy
    Williams, Monique
    Figg, William Douglas
    Dahut, William L.
    Schlom, Jeffrey
    Gulley, James L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [6] Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
    Gotto, Geoffrey T.
    Yip, Steven M.
    Shayegan, Bobby
    O'Sullivan, Dylan E.
    Wallis, Christopher J. D.
    Basappa, Naveen S.
    Cagiannos, Ilias
    Hamilton, Robert James
    Ferrario, Cristiano
    Fernandes, Ricardo
    Danielson, Brita
    Saad, Fred
    Hotte, Sebastien J.
    Brenner, Darren R.
    Cheung, Winson Y.
    Boyne, Devon J.
    Chan, Katherine
    Osborne, Brendan
    Zardan, Anousheh
    Malone, Shawn
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.
    Appukkuttan, Sreevalsa
    Williams, Troy
    Jhaveri, Jay
    Campbell, David
    Kong, Sheldon
    Kalayeh, Bashir
    Ramsey, Scott David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 63 - 63
  • [8] DEVELOPMENT AND VALIDATION OF A NOVEL PROGNOSTIC MODEL FOR PREDICTING OVERALL SURVIVAL IN TREATMENT NAIVE CASTRATION-SENSITIVE METASTATIC PROSTATE CANCER.
    Akamatsu, Shusuke
    Kubota, Masashi
    Uozumi, Ryuji
    Narita, Shintaro
    Takahashi, Masahiro
    Mitsuzuka, Koji
    Hatakeyama, Shingo
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Ishidoya, Shigeto
    Hoshi, Senji
    Ishida, Masanori
    Mizuno, Kei
    Ogura, Keiji
    Goto, Takayuki
    Terada, Naoki
    Kobayashi, Takashi
    Yamasaki, Toshinari
    Inoue, Takahiro
    Tsuchiya, Norihiko
    Ohyama, Chikara
    Arai, Yoichi
    Habuchi, Tomonori
    Morita, Satoshi
    Ogawa, Osamu
    JOURNAL OF UROLOGY, 2018, 199 (04): : E452 - E453
  • [9] Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration
    Freedland, Stephen J.
    Sandin, Rickard
    Sah, Janvi
    Emir, Birol
    Mu, Qiao
    Ratiu, Anna
    Hong, Agnes
    Serfass, Lucile
    Tagawa, Scott T.
    CANCER MEDICINE, 2021, 10 (23): : 8570 - 8580
  • [10] Real-world utilization of advanced therapies and racial disparity among patients with metastatic castration-sensitive prostate cancer (mCSPC): A Medicare database analysis.
    Freedland, Stephen J.
    Agarwal, Neeraj
    Ramaswamy, Krishnan
    Sandin, Rickard
    Russell, Dave
    Hong, Agnes
    Yang, Hongbo
    Gao, Wei
    Hagan, Kaitlin
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345